J.P. Turner & Co Capital Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
CS
J.P. Turner & Co Capital Management's XBI Position: Q3 2015 in Review
J.P. Turner & Co Capital Management reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 35% in Q3 2015, selling an estimated $141K and leaving 3,333 shares worth $207K. The position accounts for 0.21% of the portfolio, ranked #155.
J.P. Turner & Co Capital Management first reported a position in XBI in Q4 2014 and has held it in 4 quarters since. The position peaked at $429K in Q2 2015. 196 funds tracked by Wall St. Rank hold XBI as of Q3 2015.
- J.P. Turner & Co Capital Management held 3,333 shares of State Street SPDR S&P Biotech ETF worth $207K as of Q3 2015.
- J.P. Turner & Co Capital Management sold 1,788 State Street SPDR S&P Biotech ETF shares in Q3 2015, an estimated $141K.
- State Street SPDR S&P Biotech ETF made up 0.21% of J.P. Turner & Co Capital Management's portfolio in Q3 2015, its #155 holding.
- J.P. Turner & Co Capital Management first reported a position in State Street SPDR S&P Biotech ETF in Q4 2014 and has held it in 4 quarters since.
- J.P. Turner & Co Capital Management's State Street SPDR S&P Biotech ETF position peaked at $429K in Q2 2015.
- 196 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2015.
Based on J.P. Turner & Co Capital Management's 13F filing for Q3 2015, filed 4 Nov 2015.